statistiche ricercatore

Continente	#
EU - Europa	1.924
NA - Nord America	920
AS - Asia	520
SA - Sud America	84
AF - Africa	11
OC - Oceania	7
Continente sconosciuto - Info sul continente non disponibili	2
Totale	3.468

Nazione	#
DE - Germania	1.213
US - Stati Uniti d'America	902
CN - Cina	227
SG - Singapore	173
SE - Svezia	146
IT - Italia	112
GB - Regno Unito	104
UA - Ucraina	97
FR - Francia	79
BR - Brasile	74
PL - Polonia	43
IN - India	31
IE - Irlanda	30
RU - Federazione Russa	27
FI - Finlandia	23
ID - Indonesia	17
TR - Turchia	16
VN - Vietnam	12
BE - Belgio	11
CA - Canada	9
ES - Italia	8
NL - Olanda	8
IR - Iran	7
AU - Australia	6
HK - Hong Kong	6
RO - Romania	6
KR - Corea	5
MX - Messico	4
PK - Pakistan	4
BD - Bangladesh	3
DZ - Algeria	3
EC - Ecuador	3
EG - Egitto	3
UZ - Uzbekistan	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
AR - Argentina	2
AT - Austria	2
BS - Bahamas	2
CH - Svizzera	2
CO - Colombia	2
IL - Israele	2
JP - Giappone	2
LT - Lituania	2
PH - Filippine	2
PT - Portogallo	2
PY - Paraguay	2
A1 - Anonimo	1
AL - Albania	1
AM - Armenia	1
AO - Angola	1
AZ - Azerbaigian	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EU - Europa	1
GE - Georgia	1
HN - Honduras	1
HR - Croazia	1
HU - Ungheria	1
IQ - Iraq	1
LB - Libano	1
LK - Sri Lanka	1
LU - Lussemburgo	1
LV - Lettonia	1
MY - Malesia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
OM - Oman	1
SK - Slovacchia (Repubblica Slovacca)	1
UY - Uruguay	1
Totale	3.468

Nome	#
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth	483
The Role of Methane in Intestinal Diseases.	404
Small intestinal bacterial overgrowth recurrence after antibiotic therapy	393
Bacillus clausii as a treatment of small intestinal bacterial overgrowth.	259
ag)Association between hypothyroidism and small intestinal bacterial overgrowth	236
The role of small intestinal bacterial overgrowth in Parkinson's disease	215
Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?	202
-High prevalence of celiac disease in patients with lactose intolerance	202
Small intestinal bacterial overgrowth and intestinal permeability.	180
Rifaximin pharmacology and clinical implications.	151
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth	146
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.	133
Gut microbiota and obesity.	130
ag) Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.	129
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet.	124
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.	100
Totale	3.487

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	179	0	0	0	0	53	11	20	12	23	11	45	4
2021/2022	210	6	21	3	11	24	8	3	40	8	8	27	51
2022/2023	400	54	57	38	75	17	46	25	32	45	3	5	3
2023/2024	166	7	51	2	2	3	27	2	19	1	9	30	13
2024/2025	297	7	11	27	4	34	14	1	23	39	22	57	58
2025/2026	279	134	26	34	72	13	0	0	0	0	0	0	0
Totale													3.487

IRIS UniCatt